Pascal Jean-Noël Noth

Healthcare & Life Sciences Investor | Board Director | Private Equity, Partners Group

📍 Switzerland🔄 Updated September 2026💼 13 investments📅 19 years investing🗓 Last invested Sep 2024
VC🌍 Switzerland
13
Total investments
1
Early stage
0
Mid stage
2
Late stage
19y
Years active

Portfolio

6 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
Jan 2021
SERB is a growing pharmaceutical company and a dedicated ally to healthcare providers treating patients with critical conditions, focusing on emergency care and rare diseases. For over 30 years we have made treating these complex and life-threatening conditions possible; supporting clinicians, healthcare systems and governments while offering hope to patients and their families. SERB began in the 1950s as Société d’Études et de Recherches Biologiques (Company for Biologic Study and Research). Today SERB has the broadest antidote portfolio in the world, including medical countermeasures for chemical, biological, radiological and nuclear (CBRN) risks. As a fully integrated company, we have the experience and capabilities to acquire, develop, and manufacture our medicines to the highest standards, and make them available worldwide through our secure supply chain. Improving patients’ quality of life and offering hope is what motivates and inspires us. For employees, SERB is a dynamic organisation where you can expand your skills and explore new challenges. We invest in the development of all of our people and offer opportunities for advancement that allow talented employees to grow with us. Our employees that come from all walks of life. They offer a diversity of opinions and perspective that we believe leads to better business decisions and more innovative solutions to problems. We foster an open and inclusive environment that demands mutual respect and allows employees to understand each other and learn from each other’s experiences
Investor
Jan 2020
Founded in 1980, MIR specializes in the fabrication and distribution of lightweight conveyor belting and industrial conveyor products. We focus on providing value-added products and services through all our full service sales and fabrication facilities located across the United States, with our corporate headquarters located in St. Louis, Missouri. With highly-trained technicians available 24/7 for field installations and a staff with more than 1,500 aggregate years of belting experience, MIR has earned a reputation as the premier independent specialty fabricator and distributor of lightweight belting and conveyor accessories in North America. Mission Statement Our mission is to enhance MIR’s market leadership position by creating an open environment of partnership with employees and suppliers to best service our customers. Vision Statement We believe in making business an enjoyable, hassle-free experience for our customers. There is no such thing as an unreasonable request. We will create expectations for our customers and exceed them at every opportunity. Our order will be delivered on time, every time, to the best of our ability. We believe that quality products are a result of quality people. Every employee will be treated with trust and respect. Every employee will be dedicated to doing the job right for the customer in a safe, enthusiastic and productive manner. We encourage risk taking and tolerate mistakes as long as we can learn from them. We are not satisfied with mediocrity and status quo. We are in the business of providing world-class products and services to our customers. We have a responsibility to our employees, our stakeholders, and ultimately to our customers, to be recognized as the highest valued supplier.
Board Member
Sep 2018
AMMEGA is a global company located in 40 countries. We value our employees, customers, entrepreneurship and we act in an agile and responsible way. Our mission and continuous improvement culture are the foundation for a solid and sustainable business appreciated by our customers. The AMMEGA Groups businesses provide advanced and high-quality belting solutions for 20 different industries including global logistics, food production, fitness equipment, household appliances and energy production. Our global network of about 6000 employees, being a part of a high-performance organization, develop their careers in a global environment, participate in diverse teams, and take advantage of our worldwide expertise in conveyor belting, power transmission, fluid power and business services. AMMEGA’s sustainable business approach ensures our teams operate within a safe and stable work environment, with high respect for their professional development and well-being.
Investor
2007
Dress for Less is Europes leading online designer fashion outlet. Founded in 1999, it is since 2011 part of the online retail group Privalia. Dress for Less is present in over 50 countries worldwide, and is headquartered in Frankfurt am Main, Germany.
Board Member
2007
Loyalty Partner is one of the leading international providers of loyalty management solutions, operates multi-partner programmes and supplies its clients with performance marketing solutions through PAYBACK. Loyalty Partner has a workforce of 600 employees. The company is headquartered in Munich, with subsidiaries in the United States, India, the United Kingdom, France, Spain and Poland. Loyalty Partner is the centre of expertise for marketing and couponing platforms within the American Express Group.
Board Member
2007
Since 1952, Cambridge Education Group has been delivering the highest quality academic programmes, providing a valuable stepping-stone for thousands of students to progress onto the worlds leading universities and maximise their career opportunities. Whether students choose to study at one of our centres with OnCampus or Castel or complete an online programme with CEG Digital or iheed, Cambridge Education Group promises to help students Achieve More with expert tutors, innovative high-quality content, premium facilities, and the personal service our students deserve.
Experience · 16 entries
All (16)
Investments (13)
Board (9)
2024
Board Member
Sep 2024
At FairJourney Bio, we specialize in cutting-edge antibody discovery and development, offering end-to-end solutions that fast-track your research. With over a decade of expertise, our innovative technologies and seasoned team have successfully advanced 19 antibodies to clinical stages. Our adaptable partnership model empowers projects of any scale, fostering collaboration and breakthrough innovation. Whether youre in early-stage research or development, we deliver tailored, high-quality antibodies designed to meet your specific needs. Join us in revolutionizing therapeutic discovery and making lasting impacts on global healthcare.
2023
Board Member
May 2023
Sterling Pharma Solutions is a global contract development and manufacturing organisation (CDMO) with 50+ years’ experience in providing small molecule API development and manufacturing services to the pharmaceutical industry, specialising in handling challenging chemistries. Sterling manages the most complex API and API intermediate challenges from proof-of-concept to commercial manufacture, as well as Antibody Drug Conjugate (ADC) development and manufacturing services. Sterling believes that while science can be complex, partnerships should be simple. That’s why they have redefined the CDMO experience, marked by transparency, collaboration and trust; a Partnership Development and Manufacturing Organisation (PDMO®). Sterling has six facilities across the UK, USA and Europe, employing 1,350+ people, including in Cramlington and Newcastle, UK; Deeside, Wales; Cork, Ireland, as well as North Carolina and Wisconsin in the US. Find out more: www.sterlingpharmasolutions.com/sterling-facilities
2021
Board Member
Jul 2021
Founded in 1969, Pharmathen has grown to become one of the largest, vertically integrated developers of complex drug delivery technologies. Pharmathen is committed to its vision to improve people’s lives through innovation and access to affordable medicines. The company has one of the most extensive and advanced pipelines in the industry, with a focus on long acting injectables (LAI), sustained release and ophthalmic formulations. Pharmathen’s highly diversified portfolio consists of over 100 commercialized products, which are produced in its US FDA and EU-approved manufacturing facilities in Greece, serving 250 customers and accessed by patients in more than 90 countries worldwide. Pharmathen is constantly strengthening its portfolio with innovative technologies and Long-Acting Therapeutic Technologies (LATTs) and has developed three fully certified technological platforms to achieve this. As a result, Pharmathen can provide a wide range of therapies which aim to improve treatment compliance for patients and support product Life Cycle Management (LCM) opportunities for customers. Pharmathen maintains a strong presence in all major markets and collaborates with the most significant organizations in the global pharmaceutical market, supported by a broad partner network in more than 90 countries worldwide. The company ranks among the top 50 pharmaceutical research companies in Europe and is one of the largest private sector investors in research and development in Greece. Pharmathen proudly employs more than 1,600 people from over 28 different nationalities, with 54% of its total workforce and 66% of its Research Operations Team being female. The companys enduring success is attributed to a passion for creativity, strong ethics, and the dedication of its people, who share a commitment to the companys vision of making a difference in people’s lives.
Investor
Jan 2021
SERB is a growing pharmaceutical company and a dedicated ally to healthcare providers treating patients with critical conditions, focusing on emergency care and rare diseases. For over 30 years we have made treating these complex and life-threatening conditions possible; supporting clinicians, healthcare systems and governments while offering hope to patients and their families. SERB began in the 1950s as Société d’Études et de Recherches Biologiques (Company for Biologic Study and Research). Today SERB has the broadest antidote portfolio in the world, including medical countermeasures for chemical, biological, radiological and nuclear (CBRN) risks. As a fully integrated company, we have the experience and capabilities to acquire, develop, and manufacture our medicines to the highest standards, and make them available worldwide through our secure supply chain. Improving patients’ quality of life and offering hope is what motivates and inspires us. For employees, SERB is a dynamic organisation where you can expand your skills and explore new challenges. We invest in the development of all of our people and offer opportunities for advancement that allow talented employees to grow with us. Our employees that come from all walks of life. They offer a diversity of opinions and perspective that we believe leads to better business decisions and more innovative solutions to problems. We foster an open and inclusive environment that demands mutual respect and allows employees to understand each other and learn from each other’s experiences
2020
Investor
Jan 2020
Founded in 1980, MIR specializes in the fabrication and distribution of lightweight conveyor belting and industrial conveyor products. We focus on providing value-added products and services through all our full service sales and fabrication facilities located across the United States, with our corporate headquarters located in St. Louis, Missouri. With highly-trained technicians available 24/7 for field installations and a staff with more than 1,500 aggregate years of belting experience, MIR has earned a reputation as the premier independent specialty fabricator and distributor of lightweight belting and conveyor accessories in North America. Mission Statement Our mission is to enhance MIR’s market leadership position by creating an open environment of partnership with employees and suppliers to best service our customers. Vision Statement We believe in making business an enjoyable, hassle-free experience for our customers. There is no such thing as an unreasonable request. We will create expectations for our customers and exceed them at every opportunity. Our order will be delivered on time, every time, to the best of our ability. We believe that quality products are a result of quality people. Every employee will be treated with trust and respect. Every employee will be dedicated to doing the job right for the customer in a safe, enthusiastic and productive manner. We encourage risk taking and tolerate mistakes as long as we can learn from them. We are not satisfied with mediocrity and status quo. We are in the business of providing world-class products and services to our customers. We have a responsibility to our employees, our stakeholders, and ultimately to our customers, to be recognized as the highest valued supplier.
Show all 16 entries ↓
Investment activity
2007–2024 · 13 investments
20073200912011120151201812019120201202122023120241
Recent (last 2 years)Earlier